Skip to main content
SpringerLink
Log in
Book cover

Diseases of the Gastroesophageal Mucosa pp 59–74Cite as

NSAID Ulcers

Overview and Management

  • Chapter

  • 92 Accesses

Part of the book series: Clinical Gastroenterology ((CG))

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most commonly used drugs in the United States. There are greater than 100 million prescriptions written and 30 billion aspirin tablets consumed yearly (1,2). Because of the widespread use of these drugs, their adverse effects and complications have been well documented. 15–20% of people taking NSAIDs will experience some form of their toxicity, resulting in greater than $2 billion in health care costs per year (3–5).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mccarthy D. (1998) Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology. Am J Med 105 (5A): 3S - 9S.

    Article  PubMed  CAS  Google Scholar 

  2. Bjorkman DJ. (1999) Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: risk factors and frequency of complications. Am JMed 107 (6A): 3S - 10S.

    CAS  Google Scholar 

  3. Singh G, Ramey DR, Terry R, et al. (1997) NSAID related effects on the GI tract: an ever widening spectrum. Arthritis Rheum 40 (Suppl): S93.

    Google Scholar 

  4. Bjorkman DJ. (1999) Current status of Nonsteroidal anti-inflammatory drug use in the United States: risk factors and frquency of complications. Am J Med 107 (6A): 3S - 10S.

    Article  PubMed  CAS  Google Scholar 

  5. McCarthy DM. (1989) Nonsteroidal anti-inflammatory drug induced ulcers: management by traditional therapies. Gastroenterology 96 (suppl): 662–674.

    PubMed  CAS  Google Scholar 

  6. Armstrong CP, Blower AL. (1987) Nonsteroidal anti-inflammatory drugs and life threatening complications of peptic ulcerations. Gut 28: 527–532.

    Article  PubMed  CAS  Google Scholar 

  7. Carson JL, Strom BL, Soper KA, et al. (1991) The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 147: 85–88.

    Article  Google Scholar 

  8. Gabriel SE, Jaakkimainen L, Bombardier C. (1991) Risk for serious gastrointestinal complications related to the use of nonsteroidal anti-inflammatory drugs: a meta-analysis. Ann Int Med 115: 787–796.

    PubMed  CAS  Google Scholar 

  9. Langman MJS, Weil J, Wainwright P, et al. (1994) Risks of bleeding peptic ulcer associated with individual nonsteroidal anti-inflammatory drugs. Lancet 343: 1075–1078.

    Article  PubMed  CAS  Google Scholar 

  10. Silverstein FE, Graham DY, Senior JR, et al. (1995) Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non-steroidal anti-inflammatory drugs. Ann Int Med 123: 241–249.

    PubMed  CAS  Google Scholar 

  11. Scheiman, JM. (1996) NSAIDs, gastrointestinal injury, and cytoprotection. GI Clin of NA 25 (2): 279–298.

    CAS  Google Scholar 

  12. Bjorkman DJ. (1998) NSAID gastropathy. In: Clinical Gastroenterology, vol. I, (Brandt L., ed. ), Current Medicine, p. 288.

    Google Scholar 

  13. Bjorkman DJ. (1998) The effect of aspirin and nonsteroidal anti-inflammatory drugs on prostaglandins. Am J Med 105: 8S - 12S.

    Article  PubMed  CAS  Google Scholar 

  14. McCafferty DM, Granger DN, Wallace JL. (1995) Indomethacin-induced gastric injury and leukocyte adherence in arthritic versus healthy rats. Gastroenterology 109: 1173–1180.

    Article  PubMed  CAS  Google Scholar 

  15. Davenport HW. (1967) Salicylate damage to the gastric mucosal barrier. N Engl J Med 276: 1307–1312.

    Article  PubMed  CAS  Google Scholar 

  16. Schoen RT, Vender RJ. (1989) Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. Am J Med 86: 449–458.

    Article  PubMed  CAS  Google Scholar 

  17. Moore JG, Bjorkman DJ, Mitchell MD, Avots-Avotins A. (1991) Gastroenterology 100 (6): 1626–1629.

    PubMed  CAS  Google Scholar 

  18. Jaszewski R. (1990) Frequency of gastroduodenal lesions in asymptomatic patients on chronic aspirin or nonsteroidal anti-inflammatory drug therapy. J Clin Gastroenterol 12: 10–13.

    Article  PubMed  CAS  Google Scholar 

  19. Lanza FL, Royer GL Jr, Nelson RS. (1980) Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric coated aspirin on gastric and duodenal mucosa. N Engl J Med 303: 136–138.

    Article  PubMed  CAS  Google Scholar 

  20. Henry D, Dobson A, Turner C. (1993) Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 105: 1078–1088.

    PubMed  CAS  Google Scholar 

  21. Wallace JL. (1997) NSAIDs and gastroenteropathy: the second hundred years. Gastroenterology 112: 1000–1016.

    Article  PubMed  CAS  Google Scholar 

  22. Wallace JL, McKnight W, Miyasaka M, et al. (1993) Role of endothelial adhesion molecules in NSAID induced gastric mucosal injury. Am J Physiol 265: G993 - G998.

    PubMed  CAS  Google Scholar 

  23. Elliot SN, McKnight W, Cirino G, Wallace J. A nitric-oxide-releasing nonsteroidal antiinflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology 1995 109: 524–530.

    Article  Google Scholar 

  24. Chan FK, Sung JJ, Chung SC, et al. (1997) Randomised trial of eradication of Helicobacterpylori before nonsteroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 350: 975–979.

    Article  PubMed  CAS  Google Scholar 

  25. Lai KC, Lam SK, Hui WM, et al. (1998) Can eradication of Helicobacter Pylori prevent future development of peptic ulcers in patients receiving long-term continuous nonsteroidal anti-inflammatory drugs. Gastroenterology 114: A192.

    Google Scholar 

  26. Hawkey CJ, Tullassay Z, Szczepanski L, et al. (1998) Randomised, controlled trial of Helicobacter pylori eradication in patients on nonsteroidal anti-inflammatory drugs: HELP NSAIDs stud. Lancet 352: 1016–1021.

    Article  PubMed  CAS  Google Scholar 

  27. Bianchi Porro G, Parenti F, Imbesi V. (1996) Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users: response to omeprazole dual therapy. Gut 39: 22–26.

    Article  Google Scholar 

  28. Hawkey CJ, Karrasch JA, Szczepanski L, et al. (1998) Omeprazole compared with Misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs. New Engl J Med 338: 727–734.

    Article  PubMed  CAS  Google Scholar 

  29. Yeomans ND, Tulassay Z, Juhasz L, et al. (1998) A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. New Engl J Med 338: 719–726.

    Article  PubMed  CAS  Google Scholar 

  30. Bijlsma J. (1988) Treatment of endoscopy negative NSAID induced upper GI symptoms with cimetidine. Aliment Parmaco Ther 2 (suppl 1): 75–83.

    Google Scholar 

  31. Taha AS, Dahill S, Stunock RD, et al. (1994) Predicting NSAID-related ulcers: assessment of clinical and pathologic risk factors and importances of differences in NSAIDs. Gut 35: 891–895.

    Article  PubMed  CAS  Google Scholar 

  32. Fries JF, Williams CA, Block DA. (1991) The relative toxicity of nonsteroidal anti-inflammatory drugs. Arthritis Rheum 34: 1353–1360.

    Article  PubMed  CAS  Google Scholar 

  33. Fries JF, Williams CA, Bloch DA. (1991) NSAID associated gastropathy: incidence and risk factor models. Am J Med 213–221.

    Google Scholar 

  34. Garcia-Rodriquez LA, Jick H. (1994) Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 343: 769–772.

    Article  Google Scholar 

  35. Agrawal NM, Roth S, Graham DY. (1991) Misoprostol compared with sulcrafate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer: a randomized, controlled trial. Ann Int Med 115: 195–200.

    PubMed  CAS  Google Scholar 

  36. Graham DY, White RH, Moreland LW, et al. (1993) Duodenal and gstric ulcer prevention with misoprostol in arthritis patients taking NSAIDS. Ann Intern Med 199: 257–262.

    Google Scholar 

  37. Wolfe MM, Soll AH. (1988) The physiology of gastric acid secretion. New Engl J Med 319: 1707–1715.

    Article  PubMed  CAS  Google Scholar 

  38. Davies J, Collins AJ, Dixon ASJ. (1986) The influence of cimetidine on peptic ulcers in patients with arthritis taking anti-inflammatory drugs. Br J Rheum 25: 54–58.

    Article  CAS  Google Scholar 

  39. O’Laughlin JC, Silvoso GK, Ivey KJ. (1982) Resistance to medical therapy of gastric ulcers in rheumatologic disease patients taking aspirin: a double blind study with cimetidine and follow up. Dig Dis Sci 27: 976–980.

    Article  PubMed  Google Scholar 

  40. Agrawal N, Safdi M, Wruble L, et al. (1998) Effectiveness of lansoprazole in the healing of NSAID-induced gastric ulcers in patients continuing to take NSAIDS. Gastroenterology 114: A52 - A53.

    Article  Google Scholar 

  41. Hall AS, Lauritsen AH, Dalsguard V, et al. (1995) Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding. Identifying high risk groups by excess risk estimates. Scand J Gastroenterol 30: 438–444.

    Article  Google Scholar 

  42. Singh G, Rosen-Ramey D. (1998) NSAID induced gastrointestinal complications: the ARAMIS perspective-1997. Arthritis, Rheumatism, and Aging Medical Information System. J Rheumatol Suppl 51: 8–16.

    PubMed  CAS  Google Scholar 

  43. Graham DY, Agrawal NM, Roth SH. (1988) Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet 1277–1280.

    Google Scholar 

  44. Raskin JB, White RH, Jackson JE, et al. (1995) Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens. Ann Intern Med 123: 344–350.

    PubMed  CAS  Google Scholar 

  45. Robinson MG, Griffin JW Jr, Bowers J, et al. (1989) Effect of ranitidine on gastroduoenal mucosal damage induced by nonsteroidal antiinflammatory drugs. Dig Dis Sci 34: 424–428.

    Article  PubMed  CAS  Google Scholar 

  46. Ehsanullah RSB, Page MC, Tildesley G, Wood JR. (1988) Prevention of gastrointestinal damage induced by nonsteroidal anti-inflammatory drugs: controlled trial of ranitidine. Br Med J 297: 1017–1021.

    Article  CAS  Google Scholar 

  47. Taha AS, Hudson N, Hawkey CJ, et al. (1996) Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med 334: 1435–1439.

    Article  PubMed  CAS  Google Scholar 

  48. Bjorkman DJ. (1996) Nonsteroidal anti-inflammatory drug-induced gastrointestinal injury. Am JMed 101 (Suppl 1A): 25S - 32S.

    CAS  Google Scholar 

  49. Bjorkman DJ. (1999) Aspirin and NSAIDs: mechanisms of action. Clin Perspect Gastroenterol 2: 134–140.

    Google Scholar 

  50. Laine L, Sloane SR, Feretti M, Cominelli F. (1995) A randomized, double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production. Gastrointest Endosc 42: 428–433.

    Article  PubMed  CAS  Google Scholar 

  51. Lanza FL. Gastrointestinal toxicity of newer NSAIDs. Am J Gastroenterol 88: 1318–1323.

    Google Scholar 

  52. Roth SH, Tindall EA, Jain AK, et al. (1993) A controlled study comparing the effects of namebutone, ibuprofen, and ibuprofen plus misoprostol on the upper gastrointestinal tract mucosa. Arch Intern Med 153: 2565–2571.

    Article  PubMed  CAS  Google Scholar 

  53. Bjarnasson I, MacPherson A, Rotman H, et al. (1997) A randomised, double-blind, crossover comparitive endoscopy study on the gastroduodenal tolerability of a highly specific cyclooxygenase-2 inhibitor, flosulide, and naproxen. Scand J Gastroenterol 32: 126–130.

    Article  Google Scholar 

  54. Geis S, Hubbard R, Callison D, et al. (1998) Safety and efficacy of celecoxib, a specific COX-2 inhibitor, in patients with rheumatoid artthritis. Arthritis Rheum 41 99 (Suppl): S364.

    Google Scholar 

  55. Feldman M, MacMahon AT. (2000) Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity? Ann Int Med 132: 134–143.

    PubMed  CAS  Google Scholar 

  56. Langman M, Jensen DM, Watson DJ, et al. (1999) Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA 282: 1929–1933.

    Article  PubMed  CAS  Google Scholar 

  57. Bjorkman DJ. (1998) NSAID gastropathy. Pathogenesis, prevention, and treatment. A Postgraduate Medicine Special Report. Dec: 10–16.

    Google Scholar 

  58. Hawkey CJ. (1995) Future treatments for arthritis: new NSAIDS, NO NSAIDs, or no NSAIDs? Gastroenterology 109: 614–616.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. David J. Bjorkman MD, MSPH (HAS), SM (Epid)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kathryn Tessnow MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Gastroenterology and Hepatology, University of Connecticut Health Center, Farmington, CT, USA

    James W. Freston MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Bjorkman, D.J., Tessnow, K. (2001). NSAID Ulcers. In: Freston, J.W. (eds) Diseases of the Gastroesophageal Mucosa. Clinical Gastroenterology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-103-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-103-9_4

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9642-0

  • Online ISBN: 978-1-59259-103-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation